Background: Percutaneous coronary intervention (PCI) of calcified lesions has been shown to be associated with worse ischemic outcomes in several studies. These studies were limited by a high rate of bare-metal stents and drug-eluting stents (DES) of first generation use, and infrequent usage of intra-vascular ultrasound (IVUS) for PCI optimization. We sought to determine the frequency and impact of coronary calcification (CCA) among patients undergoing PCI in the contemporary drug-eluting stent era with frequent IVUS use. Methods: ADAPT-DES was a prospective, multicenter registry of patients successfully treated with one or more drug-eluting stents. Patients were stratified and 1-year outcomes compared according to the presence of CCA (per site operator assessment) of the target lesion. Results: Among 8,578 patients who underwent PCI in ADAPT-DES, CCA was present in 2646/8578 (30.8%) patients. IVUS was used in 3349 (39.0%) patients of the entire cohort. CCA was more frequent in advanced age, hyperlipidaemia, hypertension, history of renal insufficiency, presence of multi-vessel disease, low white blood cell count, and IVUS guided-PCI. The unadjusted 1-year rate of death, myocardial infarction (MI), ischemic target vessel revascularization (TVR), and major adverse cardiac events (MACE) were significantly increased in patients with presence of CCA (Table) . By multivariable analysis, also adjusting for IVUS use, the presence of CCA was an independent predictor of 1-year ischemia-driven TVR (HR [95%CI] 1.20 [1.00, 1.45], p¼0.05), myocardial infarction (HR 1.77 [1.37, 2.27], p< 0.0001), death-MI (HR 1.66 [1.35, 2.04], p< 0.0001) and MACE (HR¼1.41 [1.19, 1.68] p< 0.0001). No significant interaction was detected between the presence of CCA, IVUS use, and all ischemic outcomes. Conclusions: CCA was associated with worse outcomes after DES PCI despite high rate of IVUS usage.
Methods: Patient-level pooled data from 18 prospective randomized trials (RAVEL, E-SIRIUS, SIRIUS, C-SIRIUS, TAXUS I-II, TAXUS IV-VI, ENDEAVOR II-IV, SPIRIT II-IV, ACUITY, HORIZONS-AMI and COMPARE) were pooled. Pts were stratified by their current smoking status prior to randomization. One-year ischemic outcomes were compared between the 2 groups. Results: Among the 30, 869-pooled pts, 9,299 (30.1%) were actively smoking before PCI. At baseline, smokers were younger, less likely to have diabetes, dyslipidaemia, prior MI, PCI or CABG. Angiographically, they had less complex (severe calcifications or tortuosity) and less extensive CAD at baseline. At 1 year, smokers had lower unadjusted rates of death and cardiac death. However, after adjustment for potential cofounders, smoking status at baseline was identified as a strong independent predictor of all ischemic endpoints at 1 year, including death, cardiac death, and stent thrombosis (Table) . Conclusions: Results from this large pooled analysis of pts undergoing PCI demonstrated that the "smoker's paradox" represents a statistical artefact, most likely related to the lack of adjustment for potential cofounders. Smoking remains an important predictor of poor outcomes after PCI and should be strongly discouraged. Background: HIV is associated with premature coronary artery disease (CAD) and increased risk of adverse events. It has been shown that women have higher morbidity than men in this setting, perhaps due to the young age of this population. However, little is known about the sex-based differences angiographic pattern or burden of CAD in this population. Methods: We followed 93 consecutive patients with HIV who underwent PCI from 2003 to 2011 at our center. Quantitative coronary angiographic (QCA) analysis was 
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